Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K R Lees

Showing results (41-50 of 197) with videos related to

Pageof 20
Sort By:
Cerebrovascular Diseases (Basel, Switzerland)|November 9, 2000
Phase II clinical trial of sipatrigine (619C89) by continuous infusion in acute strokeK W Muir, L Holzapfel, K R Lees
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
Perindopril, a new angiotensin converting enzyme inhibitor--clinical pharmacological studies in healthy subjectsJ L Reid, K R Lees, L Perret
Stroke|March 1, 1994
Bilateral cerebral embolization in patients with carotid stenosisD Georgiadis, D G Grosset, K R Lees
European Journal of Neurology|February 1, 2005
Clinical features associated with medically unexplained stroke-like symptoms presenting to an acute stroke unitF S Nazir, K R Lees, I Bone
Circulation|March 14, 2001
Percutaneous closure of patent foramen ovale in patients with paradoxical embolismJ R Overell, K R Lees, I Bone
Stroke|November 1, 1993
Transhemispheric passage of microemboli in patients with unilateral internal carotid artery occlusionD Georgiadis, D G Grosset, K R Lees
International Journal of Stroke : Official Journal of the International Stroke Society|November 26, 2009
Primary end-point times, functional outcome and adverse event profile after acute ischaemic strokeM Ali, R L Sacco, K R Lees, et al.
Neurology|November 9, 2000
Interatrial septal abnormalities and stroke: a meta-analysis of case-control studiesJ R Overell, I Bone, K R Lees
American Journal of Hypertension|November 1, 1990
Tissue angiotensin converting enzyme inhibition. Relevant to clinical practice?K R Lees, R J MacFadyen, J L Reid
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 27, 2007
The therapeutic time window--theoretical and practical considerationsC Y Hsu, S H Ahmed, K R Lees
Pageof 20

Showing results (41-50 of 197) with videos related to

Sort By:
Pageof 20
Cerebrovascular Diseases (Basel, Switzerland)|November 9, 2000
Phase II clinical trial of sipatrigine (619C89) by continuous infusion in acute strokeK W Muir, L Holzapfel, K R Lees
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
Perindopril, a new angiotensin converting enzyme inhibitor--clinical pharmacological studies in healthy subjectsJ L Reid, K R Lees, L Perret
Stroke|March 1, 1994
Bilateral cerebral embolization in patients with carotid stenosisD Georgiadis, D G Grosset, K R Lees
European Journal of Neurology|February 1, 2005
Clinical features associated with medically unexplained stroke-like symptoms presenting to an acute stroke unitF S Nazir, K R Lees, I Bone
Circulation|March 14, 2001
Percutaneous closure of patent foramen ovale in patients with paradoxical embolismJ R Overell, K R Lees, I Bone
Stroke|November 1, 1993
Transhemispheric passage of microemboli in patients with unilateral internal carotid artery occlusionD Georgiadis, D G Grosset, K R Lees
International Journal of Stroke : Official Journal of the International Stroke Society|November 26, 2009
Primary end-point times, functional outcome and adverse event profile after acute ischaemic strokeM Ali, R L Sacco, K R Lees, et al.
Neurology|November 9, 2000
Interatrial septal abnormalities and stroke: a meta-analysis of case-control studiesJ R Overell, I Bone, K R Lees
American Journal of Hypertension|November 1, 1990
Tissue angiotensin converting enzyme inhibition. Relevant to clinical practice?K R Lees, R J MacFadyen, J L Reid
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 27, 2007
The therapeutic time window--theoretical and practical considerationsC Y Hsu, S H Ahmed, K R Lees
Pageof 20